BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20242023202220212020 Search 46 blog articles Image Blog Beyond the Workplace: BIOTRONIK's Commitment to Saving Lives How One Colleague’s Act Inspires a Culture of Preparedness at BIOTRONIK Image Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety. Image Blog Improving Cardiovascular Health This International Women’s Day Image Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries. Image Blog Five Cardiology Podcasts to Get Into With being able to listen in while getting something else done – such as running, commuting or cooking – podcasts offer up great ways for us to keep up with what’s going on in every field imaginable – and cardiology is no exception. Image Blog “I did not let it throw me off course” How a CLS Pacemaker Helps Cabaret Artist Wolfgang Koch Live Life to the Fullest Image Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away. Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health. Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed. Pagination Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Previous page ‹ Previous Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProductsPatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image Blog Beyond the Workplace: BIOTRONIK's Commitment to Saving Lives How One Colleague’s Act Inspires a Culture of Preparedness at BIOTRONIK
Image Blog Beyond the Workplace: BIOTRONIK's Commitment to Saving Lives How One Colleague’s Act Inspires a Culture of Preparedness at BIOTRONIK
Image Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.
Image Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.
Image Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.
Image Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.
Image Blog Five Cardiology Podcasts to Get Into With being able to listen in while getting something else done – such as running, commuting or cooking – podcasts offer up great ways for us to keep up with what’s going on in every field imaginable – and cardiology is no exception.
Image Blog Five Cardiology Podcasts to Get Into With being able to listen in while getting something else done – such as running, commuting or cooking – podcasts offer up great ways for us to keep up with what’s going on in every field imaginable – and cardiology is no exception.
Image Blog “I did not let it throw me off course” How a CLS Pacemaker Helps Cabaret Artist Wolfgang Koch Live Life to the Fullest
Image Blog “I did not let it throw me off course” How a CLS Pacemaker Helps Cabaret Artist Wolfgang Koch Live Life to the Fullest
Image Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away.
Image Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away.
Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.
Image Blog Mindfulness Isn’t Just a Buzzword at BIOTRONIK With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.
Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.
Image Blog Advancing Cardiac Patient Management Together Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.
Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with
Image BÜLACH, Switzerland Press Release Two-Year BIOPACT Randomized Controlled Trial (RCT) Analysis Demonstrates “Persistent Excellence” for Low-Profile Passeo-18 Lux DCB BIOTRONIK announced the presentation of two-year results from the investigator-initiated BIOPACT RCT by Principal Investigator Dr. Koen Deloose at the Paris Vascular Insights 2023 congress. The randomized controlled non-inferiority trial evaluated the safety and efficacy of the Passeo®-18 Lux® drug-coated balloon (DCB) catheter compared to the In.Pact Admiral DCB (Medtronic), and showed excellent results for both balloons through 24 months. 1 The prospective, multicenter, core-lab adjudicated non-inferiority trial enrolled 302 patients in Austria, Belgium, France and Switzerland with
Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one
Image AMSTERDAM, The Netherlands Press Release 12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ® Mission drug-eluting stent (DES) compared to Resolute Onyx DES (p<0.0001) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Prof. Marco Valgimigli presented the novel data in a late-breaking trial session at the European Society of Cardiology’s (ESC) Congress in Amsterdam. The results were published simultaneously in Circulation. BIOFLOW-DAPT is a prospective, multi-center, international, two-arm randomized controlled clinical study to assess the safety of one
Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for
Image BERLIN, Germany Press Release First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP* The first implant in Europe of BIOTRONIK’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts. “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for